, 2004; Nobile et al , 2006, 2008) Candida complement receptor 3

, 2004; Nobile et al., 2006, 2008). Candida complement receptor 3-related protein (CR3-RP) has been described to be a ‘mimicry’ antigen functionally comparative with the human CR3 protein expressed JNK inhibitor in neutrophils, macrophages and monocytes, with the ability to bind human complement fragment iC3b (Gilmore et

al., 1988; Hostetter et al., 1990; Hostetter, 1996). The human CR3 antigen can be detected via the monoclonal antibody (mAb) OKM1, which recognizes the α chain of CR3 and CD11b (Wright et al., 1983), but also cross-reacts with Candida CR3-RP (Heidenreich & Dierich, 1985; Bujdákováet al., 1997, 1999). The sequence of this antigen contains the DINGGG motif, which is characteristic of proteins belonging to the DING family (Bujdákováet al., 2008). This motif has already been mentioned in prokaryotic as well as in high eukaryotic organisms (Berna et al., 2009), but not in eukaryotic microorganisms. The CR3-RP has been recently reported to be a surface antigen participating in adherence to buccal epithelial cells as well as in in vitro biofilms. Moreover, Ibrutinib the immunomodulation properties of CR3-RP and the novel CR3-RP glycoconjugate effectively triggered an enhancement of immune responsiveness in the rabbit model (Bujdákováet al., 2008; Paulovičováet al., 2008). While many reports have reviewed the antifungal susceptibility/resistance of C. albicans in a mature biofilm (Henriques et al., 2005;

Seidler et al., 2006) only a few have mentioned inhibition during the adherence phase using antifungals or antibodies (Rodier et al., 2003; Cateau et al., 2007; Dorocka-Bobkowska et al., 2009; Maza et al., 2009). The lack of information about adherence and the possibility of decreasing biofilm production via a reduction in C. albicans adherence capability in the first stage of biofilm development was our motivation for searching the answer to two questions: (1) can a decrease in adherence (the first biofilm stage) affect the quantity of a mature biofilm? and (2) can blocking the C. albicans CR3-RP surface antigen by antibodies contribute Idelalisib chemical structure significantly to a reduction in adherence during biofilm formation? In this study, the standard

C. albicans strain was used (CCY 29-3-162 from the CCY Culture Collection of Yeasts, Chemical Institute, Slovak Academy of Sciences, Slovakia), originally recovered from a patient with mycotic colpitis. This strain was selected because of its high CR3-RP expression (Bujdákováet al., 1997). For comparison, the clinical isolate C. albicans with a high ability to form biofilm obtained from the urinary catheter of a patient with candidiasis was tested. Different antibodies were applied: polyclonal anti-CR3-RP antibody, prepared as described by Bujdákováet al. (2008) and OKM1 mAb (hybridoma cell culture ATCC, CRL-8026), purchased as previously described by Bujdákováet al. (1999). Titers of the antibodies were determined by enzyme-linked immunosorbent assay (ELISA) in 96-well plates (Sarstedt, Germany) (Voller, 1978).

Comments are closed.